
Chemify digitizes molecule design and production to let researchers design, synthesize, and iterate on compounds faster and more reproducibly. It does this with its Chemputation platform that combines automated robotics, a chemical programming language, and AI-driven design to execute programmable synthesis and closed-loop make-test cycles. The product is a deep-tech B2B platform integrating lab automation hardware with software for molecular design, synthesis execution, and data-driven optimization. Chemify primarily serves pharmaceutical, biotechnology, and industrial materials customers seeking to accelerate discovery and scale reproducible chemical synthesis.

Chemify digitizes molecule design and production to let researchers design, synthesize, and iterate on compounds faster and more reproducibly. It does this with its Chemputation platform that combines automated robotics, a chemical programming language, and AI-driven design to execute programmable synthesis and closed-loop make-test cycles. The product is a deep-tech B2B platform integrating lab automation hardware with software for molecular design, synthesis execution, and data-driven optimization. Chemify primarily serves pharmaceutical, biotechnology, and industrial materials customers seeking to accelerate discovery and scale reproducible chemical synthesis.
Headquarters: Glasgow, Scotland (Advanced Research Centre; Maryhill Chemifarm)
Core offering: Chemputation: a chemical programming language + robotics + AI to translate code into synthesized molecules
Founding / leadership: Founded by Professor Lee Cronin (CEO); builds on Cronin's University of Glasgow digital chemistry research
Scale: Company states 150+ employees
Funding activity: Recorded funding: Seed (Feb 1, 2022), Series A (Aug 2, 2023, lead: Triatomic Capital), Grant (Oct 1, 2024, lead: Bill & Melinda Gates Foundation)
Customers / markets: Pharma, biotechnology and industrial materials partners for accelerated discovery and reproducible synthesis
Drug discovery, biotechnology and industrial materials discovery; reproducible, scalable chemical synthesis and acceleration of molecular iteration cycles.
Chemical technology (chemistry digitisation & lab automation)
“Backed by a mix of venture investors and philanthropic/public funders, including Triatomic Capital, BlueYard Capital, 8VC, Wing Venture Capital, Insight Partners, Horizons Ventures and the Bill & Melinda Gates Foundation; Series A led by Triatomic Capital and a grant round led by the Bill & Melinda Gates Foundation.”
| Company |
|---|
Chemify is revolutionising chemistry. We are creating a future where the synthesis of previously unimaginable molecules, drugs, and materials is instantly accessible. By combining AI, robotics, and the worlds largest continually expanding database of chemical programs, we are accelerating chemical discovery to improve quality of life and extend the reach of humanity.
Chemify is expanding its Engineering Operations team to support the development, commissioning, and maintenance of robotic chemistry platforms across our Chemifarms in Glasgow and beyond. This lab-based role, reporting to the Engineering Operations Manager, involves close collaboration with software engineers, chemists, and automation specialists.
We welcome candidates with a broad range of experience; the appointment level will reflect the successful applicants background. Were looking for someone enthusiastic, service-minded, and eager to help build world-leading high-throughput chemistry infrastructure.
Occasional travel may be required. This role requires an early/late 2 shift pattern.
Key Responsibilities
Technical
Operational & Cross-Functional
Minimum Qualifications
Essential Experience
Candidates must have experience in at least one of:
Desired Skills & Attributes